XBP1 and breast cancer: In a seminal paper, Laurie Glimcher’s group identified an XBP1 gene signature using ChIP-Seq which correlated with shorter relapse free survival in two cohorts of TNBC patients, but not in ESR+ breast cancer patients [9].